MindWalk Holdings Corp. (HYFT) États Financiers et Données Historiques

MindWalk Holdings Corp. (HYFT) — Prix $1.13 HealthcareBiotechnology — NASDAQ

Derniers résultats publiés:

États financiers détaillés de MindWalk Holdings Corp. (HYFT): compte de résultat, bilan et tableau de flux de trésorerie. Suivez l'évolution des marges, de la dette, de la liquidité et de la rentabilité d'une année sur l'autre avec jusqu'à 20 ans d'historique.

Résumé de l'Analyse

MindWalk Holdings Corp. a enregistré un chiffre d'affaires de $15.3M sur le dernier exercice, avec un CAGR sur 5 ans de -3.1%.

Marges des 12 derniers mois: marge brute 60.8%, marge opérationnelle -104.4%, marge nette -105.5%.

Compte de Résultat (10 ans)

Année2017201820192020202120222023202420252026
Revenus$2.6M$5.4M$10.9M$14.7M$17.9M$19.4M$20.7M$24.5M$24.5M$15.3M
Coût des Ventes$1.2M$3.0M$5.6M$15.3M$6.4M$8.4M$9.1M$12.5M$11.0M$6.3M
Marge Brute$1.4M$2.5M$5.3M-$576292$11.5M$11.0M$11.6M$12.1M$13.5M$9.0M
R&D$660408$509248$485845$467292$2.0M$7.7M$14.1M$4.0M$4.9M$4.9M
Frais Généraux$2.0M$5.8M$8.1M$3.2M$13.3M$18.1M$19.0M$19.1M$19.0M$18.9M
Charges Opérationnelles$2.8M$7.4M$11.5M$3.7M$15.7M$27.7M$37.2M$25.8M$25.7M$23.7M
Résultat Opérationnel-$1.4M-$4.9M-$6.2M-$4.3M-$4.2M-$16.7M-$25.6M-$13.8M-$12.2M-$14.7M
EBITDA-$5.4M-$4.3M-$4.0M-$1.2M-$1.4M-$12.0M-$21.0M-$22.9M-$28.9M-$13.1M
Charges d'Intérêt$16775$84222$858323$736272$602372$85000$30000$19000$99140
Résultat Avant Impôts-$5.5M-$5.1M-$7.6M-$5.5M-$6.0M-$15.8M-$27.8M-$28.7M-$34.3M-$15.3M
Impôts-$82378$109715$4788-$362004$1.3M$861000-$1.2M-$2.6M-$4.0M-$443097
Résultat Net-$5.4M-$5.2M-$7.6M-$5.2M-$7.3M-$16.7M-$26.6M-$26.1M-$30.2M-$13.7M
BPA$-1.36$-0.57$-0.61$-0.36$-0.45$-0.87$-1.07$-1.03$-0.90$-0.30
BPA Dilué$-1.36$-0.57$-0.61$-0.36$-0.45$-0.87$-1.07$-1.03$-0.90$-0.30
Actions en Circulation (Diluées)$4.0M$9.1M$12.5M$13.6M$16.5M$19.7M$24.9M$25.6M$33.4M$46.4M

Bilan (10 ans)

Année2017201820192020202120222023202420252026
Trésorerie$2.6M$1.8M$5.5M$2.6M$41.8M$30.0M$8.3M$3.5M$10.7M$11.3M
Placements à Court Terme0000000000
Créances$469488$2.2M$2.0M$3.7M$3.6M$3.4M$3.9M$4.1M$4.8M$3.6M
Stocks$58499$412690$2.1M$818643$1.2M$1.6M$2.1M$2.1M$2.1M$491168
Actifs Courants$3.3M$4.8M$9.9M$7.7M$48.9M$37.5M$16.8M$11.5M$18.8M$16.2M
Immobilisations Corporelles$644578$1.6M$1.6M$3.2M$4.1M$3.7M$10.7M$16.7M$16.3M$4.1M
Goodwill0$4.9M$8.3M$7.9M$7.8M$19.7M$19.2M$7.7M$8.2M0
Actifs Incorporels0$4.0M$8.4M$8.3M$6.1M$32.4M$30.9M$23.6M$1.1M0
Actifs Totaux$3.9M$24.6M$28.3M$27.3M$67.0M$93.5M$77.8M$60.0M$44.4M$21.3M
Dettes Fournisseurs$664447$2.0M$1.6M$1.4M$1.3M$4.8M$2.5M$4.4M$5.3M$4.2M
Dette à Court Terme0$187814$2.8M$2.1M$801495$1.3M$82282600$456226
Passifs Courants$836915$4.3M$7.2M$7.9M$6.1M$9.3M$5.9M$8.1M$9.0M$5.8M
Dette à Long Terme0$3.6M$28717$503000$1.5M0$6.2M000
Passifs Totaux$836915$11.9M$10.3M$12.2M$10.0M$18.4M$20.0M$26.1M$20.8M$9.6M
Réserves-$4.6M-$9.7M-$17.5M-$22.5M-$29.8M-$46.5M-$73.1M-$100.3M-$128.8M-$142.5M
Capitaux Propres$3.1M$12.7M$18.1M$15.1M$56.9M$75.3M$57.8M$33.9M$23.6M$11.7M
Dette Totale0$3.8M$2.9M$4.5M$4.3M$2.8M$14.3M$13.7M$13.4M$3.5M
Dette Nette-$2.6M$2.0M-$2.5M$1.9M-$37.5M-$27.2M$6.0M$10.2M$2.7M-$7.8M
Fonds de Roulement$2.4M$498377$2.7M-$230325$42.8M$28.2M$10.9M$3.4M$9.7M$10.4M

Tableau de Flux (10 ans)

Année2017201820192020202120222023202420252026
Résultat Net-$5.4M-$5.2M-$7.6M-$4.9M-$7.3M-$16.7M-$26.6M-$27.2M-$30.2M-$14.9M
Amortissements$50609$458079$2.3M$3.4M$3.7M$3.8M$6.7M$5.7M$5.1M$1.6M
Stock-based Compensation$198032$1.2M$1.1M$739011$2.7M$3.1M$1.9M$1.5M$4450000
Variation du BFR$380689-$193383$580640-$1.1M-$1.0M$582000-$3.3M$2.4M$276990-$2.0M
Cash Flow Opérationnel-$721651-$3.4M-$3.2M-$1.4M-$600000-$9.9M-$19.8M-$4.2M-$6.4M-$12.3M
CapEx-$530750-$345487-$645058-$575642-$1.4M-$1.3M-$1.5M-$1.4M-$799000-$391896
Acquisitions$141994-$6.8M-$1.6M-$1.0M-$1.0M-$3.7M-$592000-$1460000$14.0M
Rachat d'Actions0000000000
Dividendes Payés-$90000000000000
Free Cash Flow-$1.3M-$3.8M-$3.9M-$2.0M-$2.0M-$11.2M-$21.3M-$5.6M-$7.2M-$12.7M

Croissance et Marges (10 ans)

Année2017201820192020202120222023202420252026
Croissance Revenus (annuelle)+106.9%+100.8%+34.7%+21.7%+8.1%+6.7%+18.6%+0.0%-37.5%
Croissance Résultat Net (annuelle)+4.0%-47.3%+32.0%-41.7%-127.6%-59.0%+1.7%-15.8%+54.6%
Croissance BPA (annuelle)+58.1%-7.0%+41.0%-25.0%-93.3%-23.0%+3.7%+12.6%+66.7%
Variation Actions (annuelle)+129.9%+37.7%+8.7%+20.9%+19.5%+26.5%+3.0%+30.2%+38.9%
Croissance FCF (annuelle)-200.4%-2.4%+48.9%-3.1%-451.5%-90.8%+73.5%-27.8%-75.7%
Marge Brute54.0%45.0%48.5%-3.9%64.4%56.7%56.0%49.2%55.3%58.8%
Marge Opérationnelle-52.7%-90.6%-57.0%-29.1%-23.3%-86.1%-123.9%-56.1%-49.7%-96.0%
Marge EBITDA-205.3%-79.9%-36.9%-8.4%-7.9%-61.9%-101.8%-93.6%-117.7%-85.7%
Marge Nette-204.7%-95.0%-69.7%-35.2%-41.0%-86.3%-128.5%-106.5%-123.3%-89.7%
Marge FCF-47.6%-69.1%-35.3%-13.4%-11.3%-57.7%-103.2%-23.0%-29.4%-82.7%
Taux d'Imposition Effectif1.5%-2.2%-0.1%6.5%-22.4%-5.4%4.3%9.0%11.8%2.9%

Données par Action (10 ans)

Année2017201820192020202120222023202420252026
FCF par Action$-0.32$-0.41$-0.31$-0.14$-0.12$-0.57$-0.86$-0.22$-0.22$-0.27
Dividende par Action$0.02$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Actions en Circulation (Basiques)$4.0M$9.1M$12.5M$13.6M$16.5M$19.7M$24.9M$25.6M$33.4M$46.4M

Quoi regarder en Biotech

La plupart des petites biotechs perdent de l'argent. Les analyser avec le P/E n'a aucun sens — regardez cash et pipeline.

Rentabilité

Marge brute60.79%
Marge opérationnelle-104.36%
Marge nette-105.47%

Santé financière

Dette / Capitaux propres0.50
Ratio de liquidité1.84

Ratios Clés (10 ans)

Année2017201820192020202120222023202420252026
PER-4.23-8.43-6.52-10.77-26.63-8.22-3.26-1.71-0.67-5.39
P/B7.383.442.763.503.471.871.501.330.856.39
P/V8.678.044.563.5911.027.274.201.840.824.89
Marge Brute54.0%45.0%48.5%-3.9%64.4%56.7%56.0%49.2%55.3%58.8%
Marge Opérationnelle-52.7%-90.6%-57.0%-29.1%-23.3%-86.1%-123.9%-56.1%-49.7%-96.0%
Marge Nette-204.7%-95.0%-69.7%-35.2%-41.0%-86.3%-128.5%-106.5%-123.3%-89.7%

Entreprises liées: ALXO · ATYR · BYSI · CAMP · CLNN · FBIO · GUTS

Explorer le secteur: Healthcare · Biotechnology

Plus de sections de HYFT: Vue d'ensemble · Valorisation · Statistiques · Estimations · Technique · Actionnariat · Actualités · Événements

Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions